HCIT & Life Sciences

"We have greatly appreciated AGC Partners' continuous commitment to Greenphire over the past several years and their work during our process. Hugh Hoffman's expertise and knowledge, not only in Clinical Trials but across the broader ecosystem of Life Sciences Technology and HCIT, was highly valuable in the positioning of Greenphire for our successful outcome. Coupled with the great support of Ben Howe and the 24x7 execution of the broader AGC Team, AGC Partners is highly regarded by The Riverside Company and Greenphire."

"For many closely-held business owners, the sale of their company or a large capital round is one of the biggest decisions we will ever make. Choosing the right advisor to assist in this process is critical to achieving the best value, terms and overall outcome. When I think about my experience with AGC, I can say selecting them without question was the best decision I made in the entire process. They became part of my team and worked harder than anyone I had ever seen. While in the end we signed the perfect deal, the process alone with AGC has been one of the most valuable investments of time for my company and me personally."

"We engaged AGC because of its track record, deep market knowledge, and relationships. That perspective proved invaluable to the Board and a mission-oriented shareholder group in forming a consensus to divest Exostar from joint venture to private equity ownership. I can't speak more highly of the tenacity and professionalism that Maria, Russ and the AGC team brought to the table every day to advance our strategic interests. We are excited at the prospect of moving forward under Thoma Bravo's stewardship, and the deal absolutely would not have happened without AGC. AGC has earned my highest recommendation."